AstraZeneca Full year and Q4 2023 Financial Results

CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--AstraZeneca: Revenue and EPS summary     FY 2023 Q4 2023       % Change   % Change $m Actual   CER1   $m Actual CER - Product Sales 43,789 2   4   11,323 5 5 - Alliance Revenue2   1,428 89   89   424 69 67 - Collaboration Revenue2 594 (1 ) (1 ) 277 75 74 Total Revenue   45,811 ...